Exact Sciences
EXAS
#1791
Rank
NZ$15.56 B
Marketcap
$84.08
Share price
-3.14%
Change (1 day)
-19.69%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: NZ$15.56 Billion

As of November 2024 Exact Sciences has a market cap of NZ$15.56 Billion. This makes Exact Sciences the world's 1791th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$15.56 B-26.44%
2023NZ$21.15 B52.69%
2022NZ$13.85 B-29.98%
2021NZ$19.78 B-28.35%
2020NZ$27.62 B36.26%
2019NZ$20.27 B74.92%
2018NZ$11.58 B30.84%
2017NZ$8.85 B323.62%
2016NZ$2.09 B60.38%
2015NZ$1.30 B-58%
2014NZ$3.10 B205.43%
2013NZ$1.01 B23.52%
2012NZ$0.82 B49.4%
2011NZ$0.55 B36.2%
2010NZ$0.40 B143.87%
2009NZ$0.16 B519.51%
2008NZ$26.76 M-76.54%
2007NZ$0.11 B6.06%
2006NZ$0.10 B25.84%
2005NZ$85.47 M-39.41%
2004NZ$0.14 B-53.06%
2003NZ$0.30 B-23.84%
2002NZ$0.39 B-14.77%
2001NZ$0.46 B

End of Day market cap according to different sources

On Nov 15th, 2024 the market cap of Exact Sciences was reported to be:

NZ$15.56 Billion
by Nasdaq info icon info icon
NZ$15.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.36 B-84.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.62 B-89.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.74 B-69.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.94 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$213.99 B 1,275.10%๐Ÿ‡ซ๐Ÿ‡ท France